60 Days
Source:
Financial Times
AstraZeneca shares decline after disappointing results in heart treatment trial
A UK pharmaceutical company announced that its Wainua drug did not achieve its goal of decreasing cardiovascular deaths.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)